ID R1AB_CVH22 Reviewed; 6758 AA. AC P0C6X1; Q05002; Q9DLN0; Q9DLN1; DT 10-JUN-2008, integrated into UniProtKB/Swiss-Prot. DT 10-JUN-2008, sequence version 1. DT 27-MAR-2024, entry version 113. DE RecName: Full=Replicase polyprotein 1ab; DE Short=pp1ab; DE AltName: Full=ORF1ab polyprotein; DE Contains: DE RecName: Full=Non-structural protein 1; DE Short=nsp1; DE AltName: Full=p9; DE Contains: DE RecName: Full=Non-structural protein 2; DE Short=nsp2; DE AltName: Full=p87; DE Contains: DE RecName: Full=Non-structural protein 3; DE Short=nsp3; DE EC=3.4.19.12; DE EC=3.4.22.-; DE AltName: Full=PL1-PRO/PL2-PRO; DE AltName: Full=PLP1/PLP2; DE AltName: Full=Papain-like proteinases 1/2; DE AltName: Full=p195; DE Contains: DE RecName: Full=Non-structural protein 4; DE Short=nsp4; DE AltName: Full=Peptide HD2; DE Contains: DE RecName: Full=3C-like proteinase; DE Short=3CL-PRO; DE Short=3CLp; DE EC=3.4.22.-; DE AltName: Full=M-PRO; DE AltName: Full=nsp5; DE AltName: Full=p34; DE Contains: DE RecName: Full=Non-structural protein 6; DE Short=nsp6; DE Contains: DE RecName: Full=Non-structural protein 7; DE Short=nsp7; DE AltName: Full=p5; DE Contains: DE RecName: Full=Non-structural protein 8; DE Short=nsp8; DE AltName: Full=p23; DE Contains: DE RecName: Full=Viral protein genome-linked nsp9; DE AltName: Full=Non-structural protein 9; DE Short=nsp9; DE AltName: Full=RNA-capping enzyme subunit nsp9; DE Contains: DE RecName: Full=Non-structural protein 10; DE Short=nsp10; DE AltName: Full=Growth factor-like peptide; DE Short=GFL; DE AltName: Full=p16; DE Contains: DE RecName: Full=RNA-directed RNA polymerase nsp12; DE Short=Pol; DE Short=RdRp; DE EC=2.7.7.48; DE EC=2.7.7.50; DE AltName: Full=nsp12; DE AltName: Full=p100; DE Contains: DE RecName: Full=Helicase; DE Short=Hel; DE EC=3.6.4.12; DE EC=3.6.4.13; DE AltName: Full=nsp13; DE AltName: Full=p66; DE AltName: Full=p66-HEL; DE Contains: DE RecName: Full=Exoribonuclease; DE Short=ExoN; DE EC=3.1.13.-; DE AltName: Full=nsp14; DE Contains: DE RecName: Full=Uridylate-specific endoribonuclease; DE EC=4.6.1.-; DE AltName: Full=NendoU; DE AltName: Full=nsp15; DE AltName: Full=p41; DE Contains: DE RecName: Full=Putative 2'-O-methyl transferase; DE EC=2.1.1.57; DE AltName: Full=nsp16; GN Name=rep; ORFNames=1a-1b; OS Human coronavirus 229E (HCoV-229E). OC Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes; OC Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae; OC Alphacoronavirus; Duvinacovirus. OX NCBI_TaxID=11137; OH NCBI_TaxID=9606; Homo sapiens (Human). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA]. RX PubMed=11369870; DOI=10.1099/0022-1317-82-6-1273; RA Thiel V., Herold J., Schelle B., Siddell S.G.; RT "Infectious RNA transcribed in vitro from a cDNA copy of the human RT coronavirus genome cloned in vaccinia virus."; RL J. Gen. Virol. 82:1273-1281(2001). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1-4085. RX PubMed=8337838; DOI=10.1006/viro.1993.1419; RA Herold J., Raabe T., Schelle-Prinz B., Siddell S.G.; RT "Nucleotide sequence of the human coronavirus 229E RNA polymerase locus."; RL Virology 195:680-691(1993). RN [3] RP CHARACTERIZATION OF 3CL-PRO, AND MUTAGENESIS OF HIS-3006; HIS-3028; RP ASN-3029; GLU-3074; THR-3099; CYS-3109; HIS-3127; HIS-3136 AND GLN-3267. RX PubMed=9094676; DOI=10.1128/jvi.71.5.3992-3997.1997; RA Ziebuhr J., Heusipp G., Siddell S.G.; RT "Biosynthesis, purification, and characterization of the human coronavirus RT 229E 3C-like proteinase."; RL J. Virol. 71:3992-3997(1997). RN [4] RP CHARACTERIZATION OF P41, AND SUBCELLULAR LOCATION. RX PubMed=9367364; DOI=10.1099/0022-1317-78-11-2789; RA Heusipp G., Groetzinger C., Herold J., Siddell S.G., Ziebuhr J.; RT "Identification and subcellular localization of a 41 kDa, polyprotein 1ab RT processing product in human coronavirus 229E-infected cells."; RL J. Gen. Virol. 78:2789-2794(1997). RN [5] RP CHARACTERIZATION OF HELICASE, AND MUTAGENESIS OF LYS-5284. RX PubMed=10917600; DOI=10.1017/s1355838200000728; RA Seybert A., Hegyi A., Siddell S.G., Ziebuhr J.; RT "The human coronavirus 229E superfamily 1 helicase has RNA and DNA duplex- RT unwinding activities with 5'-to-3' polarity."; RL RNA 6:1056-1068(2000). RN [6] RP ZINC-FINGER DOMAIN OF PL1-PRO, AND MUTAGENESIS OF LYS-1048; GLY-1099; RP GLY-1102; CYS-1126; CYS-1128; CYS-1154; LEU-1155; CYS-1157; CYS-1163; RP VAL-1175; CYS-1203 AND ASP-1218. RX PubMed=10329692; DOI=10.1074/jbc.274.21.14918; RA Herold J., Siddell S.G., Gorbalenya A.E.; RT "A human RNA viral cysteine proteinase that depends upon a unique Zn2+- RT binding finger connecting the two domains of a papain-like fold."; RL J. Biol. Chem. 274:14918-14925(1999). RN [7] RP ERRATUM OF PUBMED:10329692. RA Herold J., Siddell S.G., Gorbalenya A.E.; RL J. Biol. Chem. 274:21490-21490(1999). RN [8] RP PROTEOLYTIC PROCESSING OF POLYPROTEIN. RX PubMed=9847320; DOI=10.1128/jvi.73.1.177-185.1999; RA Ziebuhr J., Siddell S.G.; RT "Processing of the human coronavirus 229E replicase polyproteins by the RT virus-encoded 3C-like proteinase: identification of proteolytic products RT and cleavage sites common to pp1a and pp1ab."; RL J. Virol. 73:177-185(1999). RN [9] RP PROTEOLYTIC PROCESSING OF POLYPROTEIN, AND MUTAGENESIS OF CYS-1054 AND RP TRP-1702. RX PubMed=11431476; DOI=10.1074/jbc.m104097200; RA Ziebuhr J., Thiel V., Gorbalenya A.E.; RT "The autocatalytic release of a putative RNA virus transcription factor RT from its polyprotein precursor involves two paralogous papain-like RT proteases that cleave the same peptide bond."; RL J. Biol. Chem. 276:33220-33232(2001). RN [10] RP PROTEOLYTIC PROCESSING OF POLYPROTEIN. RX PubMed=11842254; DOI=10.1099/0022-1317-83-3-595; RA Hegyi A., Ziebuhr J.; RT "Conservation of substrate specificities among coronavirus main RT proteases."; RL J. Gen. Virol. 83:595-599(2002). RN [11] RP MUTAGENESIS OF ASN-3029. RX PubMed=11842253; DOI=10.1099/0022-1317-83-3-581; RA Hegyi A., Friebe A., Gorbalenya A.E., Ziebuhr J.; RT "Mutational analysis of the active centre of coronavirus 3C-like RT proteases."; RL J. Gen. Virol. 83:581-593(2002). RN [12] RP X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) OF 2966-3265. RX PubMed=12746549; DOI=10.1126/science.1085658; RA Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R.; RT "Coronavirus main proteinase (3CLpro) structure: basis for design of anti- RT SARS drugs."; RL Science 300:1763-1767(2003). CC -!- FUNCTION: The replicase polyprotein of coronaviruses is a CC multifunctional protein: it contains the activities necessary for the CC transcription of negative stranded RNA, leader RNA, subgenomic mRNAs CC and progeny virion RNA as well as proteinases responsible for the CC cleavage of the polyprotein into functional products. CC -!- FUNCTION: The papain-like proteinase 1 (PLP1) and papain-like CC proteinase 2 (PLP2) are responsible for the cleavages located at the N- CC terminus of the replicase polyprotein. In addition, PLP2 possesses a CC deubiquitinating/deISGylating activity and processes both 'Lys-48'- and CC 'Lys-63'-linked polyubiquitin chains from cellular substrates. PLP2 CC also antagonizes innate immune induction of type I interferon by CC blocking the nuclear translocation of host IRF-3 (By similarity). CC {ECO:0000250}. CC -!- FUNCTION: [3C-like proteinase]: Responsible for the majority of CC cleavages as it cleaves the C-terminus of replicase polyprotein at 11 CC sites. Recognizes substrates containing the core sequence [ILMVF]-Q-|- CC [SGACN]. Inhibited by the substrate-analog Cbz-Val-Asn-Ser-Thr-Leu-Gln- CC CMK. Also contains an ADP-ribose-1''-phosphate (ADRP)-binding function CC (By similarity). {ECO:0000255|PROSITE-ProRule:PRU00772}. CC -!- FUNCTION: The helicase which contains a zinc finger structure displays CC RNA and DNA duplex-unwinding activities with 5' to 3' polarity. Its CC ATPase activity is strongly stimulated by poly(U), poly(dT), poly(C), CC poly(dA), but not by poly(G). CC -!- FUNCTION: The exoribonuclease acts on both ssRNA and dsRNA in a 3' to CC 5' direction. {ECO:0000250}. CC -!- FUNCTION: Nsp7-nsp8 hexadecamer may possibly confer processivity to the CC polymerase, maybe by binding to dsRNA or by producing primers utilized CC by the latter. {ECO:0000250}. CC -!- FUNCTION: [Viral protein genome-linked nsp9]: Forms a primer, NSP9-pU, CC which is utilized by the polymerase for the initiation of RNA chains. CC Interacts with ribosome signal recognition particle RNA (SRP). Together CC with NSP8, suppress protein integration into the cell membrane, thereby CC disrupting host immune defenses. {ECO:0000250|UniProtKB:P0DTD1}. CC -!- FUNCTION: [RNA-directed RNA polymerase nsp12]: RNA-directed RNA CC polymerase that catalyzes the transcription of viral genomic and CC subgenomic RNAs. Acts in complex with nsp7 and nsp8 to transcribe both CC the minus and positive strands of genomic RNA. The kinase-like NiRAN CC domain of NSP12 attaches one or more nucleotides to the amino terminus CC of NSP9, forming a covalent RNA-protein intermediate that serves as CC transcription/replication primer. Subgenomic RNAs (sgRNAs) are formed CC by discontinuous transcription: The polymerase has the ability to pause CC at transcription-regulating sequences (TRS) and jump to the leader TRS, CC resulting in a major deletion. This creates a series of subgenomic RNAs CC that are replicated, transcribed and translated. In addition, Nsp12 is CC a subunit of the viral RNA capping enzyme that catalyzes the RNA CC guanylyltransferase reaction for genomic and sub-genomic RNAs. CC Subsequently, the NiRAN domain transfers RNA to GDP, and forms the core CC cap structure GpppA-RNA. {ECO:0000250|UniProtKB:P0DTD1}. CC -!- FUNCTION: [Uridylate-specific endoribonuclease]: Plays a role in viral CC transcription/replication and prevents the simultaneous activation of CC host cell dsRNA sensors, such as MDA5/IFIH1, OAS, and PKR (By CC similarity). Acts by degrading the 5'-polyuridines generated during CC replication of the poly(A) region of viral genomic and subgenomic RNAs. CC Catalyzes a two-step reaction in which a 2'3'-cyclic phosphate (2'3'- CC cP) is first generated by 2'-O transesterification, which is then CC hydrolyzed to a 3'-phosphate (3'-P) (By similarity). If not degraded, CC poly(U) RNA would hybridize with poly(A) RNA tails and activate host CC dsRNA sensors (By similarity). {ECO:0000250|UniProtKB:P0C6X7}. CC -!- CATALYTIC ACTIVITY: [Non-structural protein 3]: CC Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide CC and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76- CC residue protein attached to proteins as an intracellular targeting CC signal).; EC=3.4.19.12; CC -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]: CC Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate + CC RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA- CC COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395; CC EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539}; CC -!- CATALYTIC ACTIVITY: [Helicase]: CC Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12; CC -!- CATALYTIC ACTIVITY: [Helicase]: CC Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13; CC -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]: CC Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'- CC end (5'-triphosphoguanosine)-(ribonucleoside) in mRNA + diphosphate; CC Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565, CC ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50; CC Evidence={ECO:0000250|UniProtKB:P0DTD1}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67013; CC Evidence={ECO:0000250|UniProtKB:P0DTD1}; CC -!- CATALYTIC ACTIVITY: [Putative 2'-O-methyl transferase]: CC Reaction=a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside CC in mRNA + S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'- CC triphosphoguanosine)-(2'-O-methyl-ribonucleoside) in mRNA + H(+) + S- CC adenosyl-L-homocysteine; Xref=Rhea:RHEA:67020, Rhea:RHEA-COMP:17167, CC Rhea:RHEA-COMP:17168, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, CC ChEBI:CHEBI:59789, ChEBI:CHEBI:156461, ChEBI:CHEBI:167609; CC EC=2.1.1.57; Evidence={ECO:0000250|UniProtKB:P0C6X7}; CC -!- CATALYTIC ACTIVITY: [Uridylate-specific endoribonuclease]: CC Reaction=uridylyl-uridylyl-ribonucleotide-RNA = a 3'-end uridylyl- CC 2',3'-cyclophospho-uridine-RNA + a 5'-end dephospho-ribonucleoside- CC RNA; Xref=Rhea:RHEA:67732, Rhea:RHEA-COMP:13936, Rhea:RHEA- CC COMP:17334, Rhea:RHEA-COMP:17335, ChEBI:CHEBI:138284, CC ChEBI:CHEBI:173079, ChEBI:CHEBI:173080; CC Evidence={ECO:0000250|UniProtKB:P0C6X7}; CC -!- COFACTOR: [Uridylate-specific endoribonuclease]: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000250|UniProtKB:P0C6X7}; CC Note=Likely affects Nsp15 binding to RNA. CC {ECO:0000250|UniProtKB:P0C6X7}; CC -!- SUBUNIT: 3CL-PRO exists as monomer and homodimer. Eight copies of nsp7 CC and eight copies of nsp8 assemble to form a heterohexadecamer. Nsp9 is CC a dimer. Nsp10 forms a dodecamer (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC PRO_0000037299; PRO_0000037300 [P0C6X1]: rep; NbExp=4; IntAct=EBI-26366570, EBI-26366585; CC PRO_0000037301; PRO_0000037301 [P0C6X1]: rep; NbExp=5; IntAct=EBI-25708564, EBI-25708564; CC -!- SUBCELLULAR LOCATION: [Non-structural protein 3]: Host membrane CC {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Non-structural protein 4]: Host membrane CC {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Non-structural protein 6]: Host membrane CC {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Non-structural protein 7]: Host cytoplasm, host CC perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are CC localized in cytoplasmic foci, largely perinuclear. Late in infection, CC they merge into confluent complexes (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Non-structural protein 8]: Host cytoplasm, host CC perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are CC localized in cytoplasmic foci, largely perinuclear. Late in infection, CC they merge into confluent complexes (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Viral protein genome-linked nsp9]: Host CC cytoplasm, host perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 CC and nsp10 are localized in cytoplasmic foci, largely perinuclear. Late CC in infection, they merge into confluent complexes (By similarity). CC {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Non-structural protein 10]: Host cytoplasm, host CC perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are CC localized in cytoplasmic foci, largely perinuclear. Late in infection, CC they merge into confluent complexes (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Helicase]: Host endoplasmic reticulum-Golgi CC intermediate compartment {ECO:0000305}. Note=The helicase interacts CC with the N protein in membranous complexes and colocalizes with sites CC of synthesis of new viral RNA. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Uridylate-specific endoribonuclease]: Host CC cytoplasm, host perinuclear region {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Ribosomal frameshifting; Named isoforms=2; CC Name=Replicase polyprotein 1ab; Synonyms=pp1ab; CC IsoId=P0C6X1-1; Sequence=Displayed; CC Name=Replicase polyprotein 1a; Synonyms=pp1a, ORF1a polyprotein; CC IsoId=P0C6U2-1; Sequence=External; CC -!- DOMAIN: The hydrophobic domains (HD) could mediate the membrane CC association of the replication complex and thereby alter the CC architecture of the host cell membrane. CC -!- PTM: Specific enzymatic cleavages in vivo by its own proteases yield CC mature proteins. 3CL-PRO and PL-PRO proteinases are autocatalytically CC processed. {ECO:0000269|PubMed:11431476, ECO:0000269|PubMed:11842254, CC ECO:0000269|PubMed:9847320}. CC -!- MISCELLANEOUS: [Isoform Replicase polyprotein 1ab]: Produced by -1 CC ribosomal frameshifting at the 1a-1b genes boundary. CC -!- SIMILARITY: Belongs to the coronaviruses polyprotein 1ab family. CC {ECO:0000305}. CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=Proteic grace - Issue 77 of CC December 2006; CC URL="https://web.expasy.org/spotlight/back_issues/077"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF304460; AAG48591.1; -; Genomic_RNA. DR PIR; S28600; S28600. DR RefSeq; NP_073549.1; NC_002645.1. [P0C6X1-1] DR PDB; 1P9S; X-ray; 2.54 A; A/B=2966-3265. DR PDB; 2J97; X-ray; 1.75 A; A=3825-3933. DR PDB; 2J98; X-ray; 1.80 A; A/B=3825-3933. DR PDB; 3EJG; X-ray; 1.78 A; A=1270-1434. DR PDB; 4RS4; X-ray; 2.96 A; A/B/C/D/E/F=6111-6458. DR PDB; 4S1T; X-ray; 2.50 A; A/B/C/D/E/F=6111-6458. DR PDB; 7YRZ; X-ray; 1.79 A; A/B=2966-3267. DR PDBsum; 1P9S; -. DR PDBsum; 2J97; -. DR PDBsum; 2J98; -. DR PDBsum; 3EJG; -. DR PDBsum; 4RS4; -. DR PDBsum; 4S1T; -. DR PDBsum; 7YRZ; -. DR SMR; P0C6X1; -. DR IntAct; P0C6X1; 43. DR BindingDB; P0C6X1; -. DR ChEMBL; CHEMBL4888440; -. DR MEROPS; C30.003; -. DR DNASU; 918764; -. DR KEGG; vg:918764; -. DR BRENDA; 3.4.22.B14; 8801. DR BRENDA; 3.6.4.12; 8801. DR BRENDA; 3.6.4.13; 8801. DR SABIO-RK; P0C6X1; -. DR EvolutionaryTrace; P0C6X1; -. DR Proteomes; UP000006716; Genome. DR GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell. DR GO; GO:0033644; C:host cell membrane; IEA:UniProtKB-SubCell. DR GO; GO:0044220; C:host cell perinuclear region of cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW. DR GO; GO:0000175; F:3'-5'-RNA exonuclease activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA. DR GO; GO:0004843; F:cysteine-type deubiquitinase activity; IEA:UniProtKB-EC. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro. DR GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW. DR GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW. DR GO; GO:0004483; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; IEA:InterPro. DR GO; GO:0004482; F:mRNA 5'-cap (guanine-N7-)-methyltransferase activity; IEA:InterPro. DR GO; GO:0008242; F:omega peptidase activity; IEA:InterPro. DR GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW. DR GO; GO:0003724; F:RNA helicase activity; IEA:UniProtKB-EC. DR GO; GO:0003968; F:RNA-dependent RNA polymerase activity; IEA:UniProtKB-KW. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0006351; P:DNA-templated transcription; IEA:InterPro. DR GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW. DR GO; GO:0039648; P:modulation by symbiont of host protein ubiquitination; IEA:UniProtKB-KW. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0039548; P:suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of IRF3 activity; IEA:UniProtKB-KW. DR GO; GO:0019082; P:viral protein processing; IEA:InterPro. DR GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro. DR CDD; cd21409; 1B_cv_Nsp13-like; 1. DR CDD; cd21901; alpha_betaCoV_Nsp10; 1. DR CDD; cd21558; alphaCoV-Nsp6; 1. DR CDD; cd21723; alphaCoV_Nsp13-helicase; 1. DR CDD; cd21660; alphaCoV_Nsp14; 1. DR CDD; cd21514; alphaCoV_Nsp2_HCoV-229E-like; 1. DR CDD; cd21665; alphaCoV_Nsp5_Mpro; 1. DR CDD; cd21826; alphaCoV_Nsp7; 1. DR CDD; cd21830; alphaCoV_Nsp8; 1. DR CDD; cd21897; alphaCoV_Nsp9; 1. DR CDD; cd21731; alphaCoV_PLPro; 1. DR CDD; cd21588; alphaCoV_RdRp; 1. DR CDD; cd21473; cv_Nsp4_TM; 1. DR CDD; cd21167; M_alpha_beta_cv_Nsp15-like; 1. DR CDD; cd21557; Macro_X_Nsp3-like; 1. DR CDD; cd21161; NendoU_cv_Nsp15-like; 1. DR CDD; cd21171; NTD_alpha_betaCoV_Nsp15-like; 1. DR CDD; cd21875; PEDV-like_alphaCoV_Nsp1; 1. DR CDD; cd21689; stalk_CoV_Nsp13-like; 1. DR CDD; cd21712; TM_Y_alphaCoV_Nsp3_C; 1. DR CDD; cd21401; ZBD_cv_Nsp13-like; 1. DR Gene3D; 1.10.8.1190; -; 2. DR Gene3D; 3.40.50.11580; -; 1. DR Gene3D; 6.10.140.2090; -; 1. DR Gene3D; 1.10.150.420; Coronavirus nonstructural protein 4 C-terminus; 1. DR Gene3D; 3.40.220.10; Leucine Aminopeptidase, subunit E, domain 1; 1. DR Gene3D; 1.10.1840.10; main proteinase (3clpro) structure, domain 3; 1. DR Gene3D; 3.30.160.820; Nsp15 N-terminal domain-like; 1. DR Gene3D; 1.10.8.370; nsp7 replicase; 1. DR Gene3D; 3.30.70.3540; Nsp8 replicase, head domain; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2. DR Gene3D; 2.40.10.250; Replicase NSP9; 1. DR Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2. DR Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1. DR InterPro; IPR027351; (+)RNA_virus_helicase_core_dom. DR InterPro; IPR046443; a/bCoV_NSP1_glob. DR InterPro; IPR046440; AV_NSP11N_COV_NSP15M. DR InterPro; IPR043608; CoV_NSP15_M. DR InterPro; IPR043606; CoV_NSP15_N. DR InterPro; IPR043613; CoV_NSP2_C. DR InterPro; IPR047573; CoV_NSP2_M. DR InterPro; IPR043611; CoV_NSP3_C. DR InterPro; IPR047566; CoV_NSP3_Y3. DR InterPro; IPR032505; CoV_NSP4_C. DR InterPro; IPR043612; CoV_NSP4_N. DR InterPro; IPR043502; DNA/RNA_pol_sf. DR InterPro; IPR041679; DNA2/NAM7-like_C. DR InterPro; IPR037227; EndoU-like. DR InterPro; IPR002589; Macro_dom. DR InterPro; IPR043472; Macro_dom-like. DR InterPro; IPR044371; Macro_X_NSP3-like. DR InterPro; IPR046435; N7_MTase_CoV. DR InterPro; IPR043609; NendoU_nidovirus. DR InterPro; IPR044863; NIRAN. DR InterPro; IPR046438; NIV_2_O_MTASE. DR InterPro; IPR046436; NIV_EXON. DR InterPro; IPR036333; NSP10_sf_CoV. DR InterPro; IPR047570; NSP12_IF_CoV. DR InterPro; IPR044343; NSP13_1B_dom_CoV. DR InterPro; IPR047912; Nsp13_helicase_alphaCoV. DR InterPro; IPR048673; NSP13_stalk_CoV. DR InterPro; IPR048672; NSP13_ZBD_CoV. DR InterPro; IPR027352; NSP13_ZBD_CoV-like. DR InterPro; IPR044313; NSP14_alphaCoV. DR InterPro; IPR009466; NSP14_CoV. DR InterPro; IPR044330; NSP15_alpha_betaCoV_N. DR InterPro; IPR044322; NSP15_M_alpha_beta_CoV. DR InterPro; IPR043174; NSP15_middle_sf. DR InterPro; IPR042515; NSP15_N_CoV. DR InterPro; IPR044401; NSP15_NendoU_CoV. DR InterPro; IPR009461; NSP16_CoV-like. DR InterPro; IPR044385; NSP2_HCoV-229E-like. DR InterPro; IPR043615; NSP2_N_CoV. DR InterPro; IPR044357; NSP3_Ubl1_dom_CoV. DR InterPro; IPR044353; Nsp3_Ubl2_dom_CoV. DR InterPro; IPR038123; NSP4_C_sf_CoV. DR InterPro; IPR044309; NSP5_Mpro_alphaCoV. DR InterPro; IPR044369; NSP6_alphaCoV. DR InterPro; IPR043610; NSP6_CoV. DR InterPro; IPR014828; NSP7_CoV. DR InterPro; IPR037204; NSP7_sf_CoV. DR InterPro; IPR014829; NSP8_CoV. DR InterPro; IPR037230; NSP8_sf_CoV. DR InterPro; IPR014822; NSP9_CoV. DR InterPro; IPR036499; NSP9_sf_CoV. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR013016; Peptidase_C16_CoV. DR InterPro; IPR008740; Peptidase_C30_CoV. DR InterPro; IPR043477; Peptidase_C30_dom3_CoV. DR InterPro; IPR009003; Peptidase_S1_PA. DR InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin. DR InterPro; IPR043178; PLpro_thumb_sf_CoV. DR InterPro; IPR044356; RdRp_alphaCoV. DR InterPro; IPR046441; RdRp_CoV. DR InterPro; IPR009469; RdRp_N_CoV. DR InterPro; IPR001205; RNA-dir_pol_C. DR InterPro; IPR007094; RNA-dir_pol_PSvirus. DR InterPro; IPR018995; RNA_synth_NSP10_CoV. DR InterPro; IPR029063; SAM-dependent_MTases_sf. DR PANTHER; PTHR43788; DNA2/NAM7 HELICASE FAMILY MEMBER; 1. DR PANTHER; PTHR43788:SF8; HELICASE WITH ZINC FINGER 2; 1. DR Pfam; PF13087; AAA_12; 1. DR Pfam; PF13604; AAA_30; 1. DR Pfam; PF06471; CoV_ExoN; 1. DR Pfam; PF06460; CoV_Methyltr_2; 1. DR Pfam; PF09401; CoV_NSP10; 1. DR Pfam; PF20631; CoV_NSP13_1B; 1. DR Pfam; PF20633; CoV_NSP13_stalk; 1. DR Pfam; PF20632; CoV_NSP13_ZBD; 1. DR Pfam; PF19215; CoV_NSP15_C; 1. DR Pfam; PF19216; CoV_NSP15_M; 1. DR Pfam; PF19219; CoV_NSP15_N; 1. DR Pfam; PF19212; CoV_NSP2_C; 2. DR Pfam; PF19211; CoV_NSP2_N; 1. DR Pfam; PF19218; CoV_NSP3_C; 1. DR Pfam; PF16348; CoV_NSP4_C; 1. DR Pfam; PF19217; CoV_NSP4_N; 1. DR Pfam; PF19213; CoV_NSP6; 1. DR Pfam; PF08716; CoV_NSP7; 1. DR Pfam; PF08717; CoV_NSP8; 1. DR Pfam; PF08710; CoV_NSP9; 1. DR Pfam; PF08715; CoV_peptidase; 2. DR Pfam; PF06478; CoV_RPol_N; 1. DR Pfam; PF01661; Macro; 1. DR Pfam; PF05409; Peptidase_C30; 1. DR Pfam; PF00680; RdRP_1; 1. DR SMART; SM00506; A1pp; 1. DR SUPFAM; SSF144246; Coronavirus NSP10-like; 1. DR SUPFAM; SSF140367; Coronavirus NSP7-like; 1. DR SUPFAM; SSF143076; Coronavirus NSP8-like; 1. DR SUPFAM; SSF56672; DNA/RNA polymerases; 1. DR SUPFAM; SSF142877; EndoU-like; 1. DR SUPFAM; SSF52949; Macro domain-like; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR SUPFAM; SSF101816; Replicase NSP9; 1. DR SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1. DR SUPFAM; SSF50494; Trypsin-like serine proteases; 1. DR PROSITE; PS51961; AV_NSP11N_COV_NSP15M; 1. DR PROSITE; PS51993; COV_3ECTO; 1. DR PROSITE; PS51952; COV_EXON_MTASE_COACT; 1. DR PROSITE; PS51954; COV_N7_MTASE; 1. DR PROSITE; PS51962; COV_NSP1; 1. DR PROSITE; PS52000; COV_NSP12_IF; 1. DR PROSITE; PS51948; COV_NSP12_RDRP; 1. DR PROSITE; PS51960; COV_NSP15_NTD; 1. DR PROSITE; PS51991; COV_NSP2_C; 1. DR PROSITE; PS51990; COV_NSP2_M; 1. DR PROSITE; PS51989; COV_NSP2_N; 1. DR PROSITE; PS51992; COV_NSP3_Y; 1. DR PROSITE; PS51943; COV_NSP3A_UBL; 1. DR PROSITE; PS51944; COV_NSP3D_UBL; 1. DR PROSITE; PS51946; COV_NSP4C; 1. DR PROSITE; PS51949; COV_NSP7; 1. DR PROSITE; PS51950; COV_NSP8; 1. DR PROSITE; PS51951; COV_NSP9_SSRNA_BD; 1. DR PROSITE; PS51653; CV_ZBD; 1. DR PROSITE; PS51442; M_PRO; 1. DR PROSITE; PS51154; MACRO; 1. DR PROSITE; PS51958; NENDOU; 1. DR PROSITE; PS51947; NIRAN; 1. DR PROSITE; PS51955; NIV_2_O_MTASE; 1. DR PROSITE; PS51953; NIV_EXON; 1. DR PROSITE; PS51124; PEPTIDASE_C16; 2. DR PROSITE; PS51657; PSRV_HELICASE; 1. DR PROSITE; PS50507; RDRP_SSRNA_POS; 1. PE 1: Evidence at protein level; KW 3D-structure; Activation of host autophagy by virus; ATP-binding; KW Disulfide bond; Endonuclease; Exonuclease; Helicase; Host cytoplasm; KW Host membrane; Host-virus interaction; Hydrolase; KW Inhibition of host innate immune response by virus; KW Inhibition of host IRF3 by virus; Inhibition of host RLR pathway by virus; KW Lyase; Membrane; Metal-binding; Methyltransferase; KW Modulation of host ubiquitin pathway by viral deubiquitinase; KW Modulation of host ubiquitin pathway by virus; Nuclease; KW Nucleotide-binding; Nucleotidyltransferase; Protease; Reference proteome; KW Repeat; Ribosomal frameshifting; RNA-binding; RNA-directed RNA polymerase; KW Thiol protease; Transferase; Transmembrane; Transmembrane helix; KW Ubl conjugation pathway; Viral immunoevasion; Viral RNA replication; Zinc; KW Zinc-finger. FT CHAIN 1..111 FT /note="Non-structural protein 1" FT /id="PRO_0000037293" FT CHAIN 112..897 FT /note="Non-structural protein 2" FT /id="PRO_0000037294" FT CHAIN 898..2484 FT /note="Non-structural protein 3" FT /id="PRO_0000037295" FT CHAIN 2485..2965 FT /note="Non-structural protein 4" FT /id="PRO_0000037296" FT CHAIN 2966..3267 FT /note="3C-like proteinase" FT /id="PRO_0000037297" FT CHAIN 3268..3546 FT /note="Non-structural protein 6" FT /id="PRO_0000037298" FT CHAIN 3547..3629 FT /note="Non-structural protein 7" FT /id="PRO_0000037299" FT CHAIN 3630..3824 FT /note="Non-structural protein 8" FT /id="PRO_0000037300" FT CHAIN 3825..3933 FT /note="Viral protein genome-linked nsp9" FT /id="PRO_0000037301" FT CHAIN 3934..4068 FT /note="Non-structural protein 10" FT /id="PRO_0000037302" FT CHAIN 4069..4995 FT /note="RNA-directed RNA polymerase nsp12" FT /id="PRO_0000037303" FT CHAIN 4996..5592 FT /note="Helicase" FT /id="PRO_0000037304" FT CHAIN 5593..6110 FT /note="Exoribonuclease" FT /evidence="ECO:0000250" FT /id="PRO_0000037305" FT CHAIN 6111..6458 FT /note="Uridylate-specific endoribonuclease" FT /evidence="ECO:0000250" FT /id="PRO_0000037306" FT CHAIN 6459..6758 FT /note="Putative 2'-O-methyl transferase" FT /evidence="ECO:0000250" FT /id="PRO_0000037307" FT TRANSMEM 1925..1945 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1998..2018 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2068..2088 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2095..2115 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2491..2511 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2731..2751 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2755..2775 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2782..2802 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2809..2829 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2834..2854 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 3281..3301 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 3304..3324 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 3328..3348 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 3367..3387 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 3401..3421 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 3422..3442 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 3467..3487 FT /note="Helical" FT /evidence="ECO:0000255" FT DOMAIN 2..109 FT /note="CoV Nsp1 globular" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01307" FT DOMAIN 113..359 FT /note="CoV Nsp2 N-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01333" FT DOMAIN 389..775 FT /note="CoV Nsp2 middle" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01334" FT DOMAIN 773..897 FT /note="CoV Nsp2 C-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01335" FT DOMAIN 898..993 FT /note="Ubiquitin-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00214" FT DOMAIN 1016..1268 FT /note="Peptidase C16 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT DOMAIN 1269..1436 FT /note="Macro" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00490" FT DOMAIN 1600..1655 FT /note="Ubiquitin-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00214" FT DOMAIN 1663..1914 FT /note="Peptidase C16 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT DOMAIN 2005..2070 FT /note="3Ecto" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01337" FT DOMAIN 2144..2483 FT /note="CoV Nsp3 Y" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT DOMAIN 2870..2965 FT /note="Nsp4C" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01291" FT DOMAIN 2966..3267 FT /note="Peptidase C30" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00772" FT DOMAIN 3547..3629 FT /note="RdRp Nsp7 cofactor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01294" FT DOMAIN 3630..3824 FT /note="RdRp Nsp8 cofactor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01295" FT DOMAIN 3825..3933 FT /note="Nsp9 ssRNA-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01296" FT DOMAIN 3934..4072 FT /note="ExoN/MTase coactivator" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT DOMAIN 4074..4323 FT /note="NiRAN" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01292" FT DOMAIN 4329..4427 FT /note="Nsp12 Interface" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01344" FT DOMAIN 4428..4995 FT /note="Nsp12 RNA-dependent RNA polymerase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT DOMAIN 4675..4837 FT /note="RdRp catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00539" FT DOMAIN 4996..5108 FT /note="CV ZBD" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT DOMAIN 5253..5434 FT /note="(+)RNA virus helicase ATP-binding" FT DOMAIN 5435..5607 FT /note="(+)RNA virus helicase C-terminal" FT DOMAIN 5664..5878 FT /note="ExoN" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT DOMAIN 5887..6108 FT /note="N7-MTase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01299" FT DOMAIN 6111..6171 FT /note="Nsp15 N-terminal oligomerization" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01305" FT DOMAIN 6172..6298 FT /note="AV-Nsp11N/CoV-Nsp15M" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01306" FT DOMAIN 6315..6455 FT /note="NendoU" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01303" FT DOMAIN 6459..6755 FT /note="Nidovirus-type SAM-dependent 2'-O-MTase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01300" FT ZN_FING 1126..1157 FT /note="C4-type 1; degenerate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ZN_FING 1780..1815 FT /note="C4-type 2; atypical" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ZN_FING 4007..4023 FT /evidence="ECO:0000250" FT ZN_FING 4049..4062 FT /evidence="ECO:0000250" FT REGION 246..266 FT /note="C4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01333" FT REGION 1925..2115 FT /note="HD1" FT REGION 2144..2234 FT /note="Y1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT REGION 2148..2161 FT /note="ZF1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT REGION 2194..2204 FT /note="ZF2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT REGION 2235..2483 FT /note="CoV-Y" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT REGION 2235..2324 FT /note="Y2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT REGION 2325..2381 FT /note="Y3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT REGION 2382..2483 FT /note="Y4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT REGION 2491..2854 FT /note="HD2" FT REGION 3281..3487 FT /note="HD3" FT REGION 4430..4644 FT /note="RdRp Fingers N-ter" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT REGION 4645..4683 FT /note="RdRp Palm N-ter" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT REGION 4684..4742 FT /note="RdRp Fingers C-ter" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT REGION 4743..4878 FT /note="RdRp Palm C-ter" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT REGION 4879..4995 FT /note="RdRp Thumb" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT REGION 5999..6013 FT /note="GpppA-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01299" FT ACT_SITE 1054 FT /note="For PL1-PRO activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ACT_SITE 1205 FT /note="For PL1-PRO activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ACT_SITE 1218 FT /note="For PL1-PRO activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ACT_SITE 1701 FT /note="For PL2-PRO activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ACT_SITE 1863 FT /note="For PL2-PRO activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ACT_SITE 1868 FT /note="For PL2-PRO activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT ACT_SITE 3006 FT /note="For 3CL-PRO activity" FT ACT_SITE 3109 FT /note="For 3CL-PRO activity" FT ACT_SITE 4822 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT ACT_SITE 4823 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT ACT_SITE 4824 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT ACT_SITE 5682 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT ACT_SITE 5684 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT ACT_SITE 5783 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT ACT_SITE 5859 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT ACT_SITE 5864 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT ACT_SITE 6345 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01303" FT ACT_SITE 6360 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01303" FT ACT_SITE 6401 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01303" FT ACT_SITE 6503 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01300" FT ACT_SITE 6587 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01300" FT ACT_SITE 6627 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01300" FT ACT_SITE 6660 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01300" FT BINDING 246 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01333" FT BINDING 248 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01333" FT BINDING 265 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01333" FT BINDING 266 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01333" FT BINDING 1780 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT BINDING 1783 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT BINDING 1813 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT BINDING 1815 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00444" FT BINDING 2148 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 2153 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 2158 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 2161 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 2194 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 2197 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 2201 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 2204 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01336" FT BINDING 4007 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4010 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4016 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4023 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4049 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4052 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4060 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4062 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01297" FT BINDING 4358 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01344" FT BINDING 4364 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01344" FT BINDING 4369 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01344" FT BINDING 4373 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01344" FT BINDING 4550 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT BINDING 4705 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT BINDING 4708 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT BINDING 4709 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01293" FT BINDING 5000 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5003 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5011 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5014 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5021 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5024 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5028 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5034 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5045 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5050 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5067 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5070 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00986" FT BINDING 5278..5285 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000305" FT BINDING 5799 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5801 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5817 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5820 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5848 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5852 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5855 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5870 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01298" FT BINDING 5922..5928 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01299" FT BINDING 6037 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01299" FT BINDING 6054 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01299" FT BINDING 6065 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01299" FT BINDING 6068 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01299" FT SITE 111..112 FT /note="Cleavage; by PL1-PRO" FT SITE 897..898 FT /note="Cleavage; by PL1-PRO" FT SITE 2484..2485 FT /note="Cleavage; by PL2-PRO" FT SITE 2965..2966 FT /note="Cleavage; by 3CL-PRO" FT SITE 3267..3268 FT /note="Cleavage; by 3CL-PRO" FT SITE 3546..3547 FT /note="Cleavage; by 3CL-PRO" FT SITE 3629..3630 FT /note="Cleavage; by 3CL-PRO" FT SITE 3824..3825 FT /note="Cleavage; by 3CL-PRO" FT SITE 3933..3934 FT /note="Cleavage; by 3CL-PRO" FT SITE 4068..4069 FT /note="Cleavage; by 3CL-PRO" FT SITE 4995..4996 FT /note="Cleavage; by 3CL-PRO" FT SITE 5592..5593 FT /note="Cleavage; by 3CL-PRO" FT SITE 6110..6111 FT /note="Cleavage; by 3CL-PRO" FT SITE 6458..6459 FT /note="Cleavage; by 3CL-PRO" FT DISULFID 2021..2048 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01337" FT DISULFID 2039..2045 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01337" FT MUTAGEN 1048 FT /note="K->E: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1054 FT /note="C->A,G,S: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:11431476" FT MUTAGEN 1099 FT /note="G->A: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1099 FT /note="G->P: No effect." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1102 FT /note="G->A,S: No effect." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1126 FT /note="C->D,H: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1128 FT /note="C->A,D,P: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1154 FT /note="C->A,H,D: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1155 FT /note="Missing: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1157 FT /note="C->A,D,H,P: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1163 FT /note="C->A,D: No effect." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1175 FT /note="V->H,P: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1175 FT /note="V->N,T: No effect." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1203 FT /note="C->A: Complete loss of PL1-PRO activity." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1203 FT /note="C->D: No effect." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1218 FT /note="D->A,E,H,K,N,Q: No effect." FT /evidence="ECO:0000269|PubMed:10329692" FT MUTAGEN 1702 FT /note="W->L: Complete loss of PL2-PRO activity." FT /evidence="ECO:0000269|PubMed:11431476" FT MUTAGEN 3006 FT /note="H->G,S,T,Y: Complete loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3028 FT /note="H->G,T: No loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3029 FT /note="N->A,D,E,Q: Increase of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:11842253, FT ECO:0000269|PubMed:9094676" FT MUTAGEN 3029 FT /note="N->G: No loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:11842253, FT ECO:0000269|PubMed:9094676" FT MUTAGEN 3029 FT /note="N->P: 95% loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:11842253, FT ECO:0000269|PubMed:9094676" FT MUTAGEN 3074 FT /note="E->H: No loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3099 FT /note="T->D: Complete loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3109 FT /note="C->P,S,V: Complete loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3127 FT /note="H->S: Complete loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3136 FT /note="H->A: 67% loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3136 FT /note="H->S: 77% loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3136 FT /note="H->T: 93% loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 3267 FT /note="Q->A: No loss of 3CL-PRO activity." FT /evidence="ECO:0000269|PubMed:9094676" FT MUTAGEN 5284 FT /note="K->A: Almost complete loss of helicase activity." FT /evidence="ECO:0000269|PubMed:10917600" FT CONFLICT 1982 FT /note="A -> Q (in Ref. 1; Ref/1)" FT /evidence="ECO:0000305" FT CONFLICT 4042 FT /note="F -> S (in Ref. 1; Ref/1)" FT /evidence="ECO:0000305" FT STRAND 1275..1278 FT /evidence="ECO:0007829|PDB:3EJG" FT STRAND 1281..1285 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 1288..1294 FT /evidence="ECO:0007829|PDB:3EJG" FT STRAND 1298..1304 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 1313..1321 FT /evidence="ECO:0007829|PDB:3EJG" FT TURN 1322..1324 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 1325..1337 FT /evidence="ECO:0007829|PDB:3EJG" FT STRAND 1345..1350 FT /evidence="ECO:0007829|PDB:3EJG" FT STRAND 1353..1359 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 1367..1380 FT /evidence="ECO:0007829|PDB:3EJG" FT STRAND 1381..1383 FT /evidence="ECO:0007829|PDB:3EJG" FT STRAND 1385..1387 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 1393..1395 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 1399..1409 FT /evidence="ECO:0007829|PDB:3EJG" FT STRAND 1415..1419 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 1422..1433 FT /evidence="ECO:0007829|PDB:3EJG" FT HELIX 3829..3831 FT /evidence="ECO:0007829|PDB:2J98" FT STRAND 3834..3842 FT /evidence="ECO:0007829|PDB:2J97" FT HELIX 3843..3845 FT /evidence="ECO:0007829|PDB:2J97" FT STRAND 3847..3855 FT /evidence="ECO:0007829|PDB:2J97" FT STRAND 3858..3860 FT /evidence="ECO:0007829|PDB:2J98" FT STRAND 3862..3869 FT /evidence="ECO:0007829|PDB:2J97" FT STRAND 3873..3878 FT /evidence="ECO:0007829|PDB:2J97" FT STRAND 3881..3883 FT /evidence="ECO:0007829|PDB:2J97" FT STRAND 3885..3889 FT /evidence="ECO:0007829|PDB:2J97" FT STRAND 3893..3897 FT /evidence="ECO:0007829|PDB:2J97" FT STRAND 3904..3911 FT /evidence="ECO:0007829|PDB:2J97" FT HELIX 3916..3930 FT /evidence="ECO:0007829|PDB:2J97" FT HELIX 6112..6122 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6134..6137 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6140..6144 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6149..6154 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6157..6159 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6161..6169 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6174..6176 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6180..6184 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6189..6194 FT /evidence="ECO:0007829|PDB:4S1T" FT TURN 6198..6201 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6202..6211 FT /evidence="ECO:0007829|PDB:4S1T" FT TURN 6213..6215 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6223..6226 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6232..6238 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6240..6248 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6252..6254 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6262..6267 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6270..6273 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6287..6293 FT /evidence="ECO:0007829|PDB:4S1T" FT TURN 6311..6313 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6319..6326 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6329..6336 FT /evidence="ECO:0007829|PDB:4S1T" FT TURN 6339..6342 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6343..6346 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6352..6355 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6362..6371 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6374..6380 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6386..6394 FT /evidence="ECO:0007829|PDB:4S1T" FT TURN 6395..6398 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6399..6407 FT /evidence="ECO:0007829|PDB:4S1T" FT HELIX 6411..6418 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6423..6434 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6437..6446 FT /evidence="ECO:0007829|PDB:4S1T" FT STRAND 6449..6455 FT /evidence="ECO:0007829|PDB:4S1T" SQ SEQUENCE 6758 AA; 754163 MW; B7EC2ABD7FE4EC1A CRC64; MACNRVTLAV ASDSEISANG CSTIAQAVRR YSEAASNGFR ACRFVSLDLQ DCIVGIADDT YVMGLHGNQT LFCNIMKFSD RPFMLHGWLV FSNSNYLLEE FDVVFGKRGG GNVTYTDQYL CGADGKPVMS EDLWQFVDHF GENEEIIING HTYVCAWLTK RKPLDYKRQN NLAIEEIEYV HGDALHTLRN GSVLEMAKEV KTSSKVVLSD ALDKLYKVFG SPVMTNGSNI LEAFTKPVFI SALVQCTCGT KSWSVGDWTG FKSSCCNVIS NKLCVVPGNV KPGDAVITTQ QAGAGIKYFC GMTLKFVANI EGVSVWRVIA LQSVDCFVAS STFVEEEHVN RMDTFCFNVR NSVTDECRLA MLGAEMTSNV RRQVASGVID ISTGWFDVYD DIFAESKPWF VRKAEDIFGP CWSALASALK QLKVTTGELV RFVKSICNSA VAVVGGTIQI LASVPEKFLN AFDVFVTAIQ TVFDCAVETC TIAGKAFDKV FDYVLLDNAL VKLVTTKLKG VRERGLNKVK YATVVVGSTE EVKSSRVERS TAVLTIANNY SKLFDEGYTV VIGDVAYFVS DGYFRLMASP NSVLTTAVYK PLFAFNVNVM GTRPEKFPTT VTCENLESAV LFVNDKITEF QLDYSIDVID NEIIVKPNIS LCVPLYVRDY VDKWDDFCRQ YSNESWFEDD YRAFISVLDI TDAAVKAAES KAFVDTIVPP CPSILKVIDG GKIWNGVIKN VNSVRDWLKS LKLNLTQQGL LGTCAKRFKR WLGILLEAYN AFLDTVVSTV KIGGLTFKTY AFDKPYIVIR DIVCKVENKT EAEWIELFPH NDRIKSFSTF ESAYMPIADP THFDIEEVEL LDAEFVEPGC GGILAVIDEH VFYKKDGVYY PSNGTNILPV AFTKAAGGKV SFSDDVEVKD IEPVYRVKLC FEFEDEKLVD VCEKAIGKKI KHEGDWDSFC KTIQSALSVV SCYVNLPTYY IYDEEGGNDL SLPVMISEWP LSVQQAQQEA TLPDIAEDVV DQVEEVNSIF DIETVDVKHD VSPFEMPFEE LNGLKILKQL DNNCWVNSVM LQIQLTGILD GDYAMQFFKM GRVAKMIERC YTAEQCIRGA MGDVGLCMYR LLKDLHTGFM VMDYKCSCTS GRLEESGAVL FCTPTKKAFP YGTCLNCNAP RMCTIRQLQG TIIFVQQKPE PVNPVSFVVK PVCSSIFRGA VSCGHYQTNI YSQNLCVDGF GVNKIQPWTN DALNTICIKD ADYNAKVEIS VTPIKNTVDT TPKEEFVVKE KLNAFLVHDN VAFYQGDVDT VVNGVDFDFI VNAANENLAH GGGLAKALDV YTKGKLQRLS KEHIGLAGKV KVGTGVMVEC DSLRIFNVVG PRKGKHERDL LIKAYNTINN EQGTPLTPIL SCGIFGIKLE TSLEVLLDVC NTKEVKVFVY TDTEVCKVKD FVSGLVNVQK VEQPKIEPKP VSVIKVAPKP YRVDGKFSYF TEDLLCVADD KPIVLFTDSM LTLDDRGLAL DNALSGVLSA AIKDCVDINK AIPSGNLIKF DIGSVVVYMC VVPSEKDKHL DNNVQRCTRK LNRLMCDIVC TIPADYILPL VLSSLTCNVS FVGELKAAEA KVITIKVTED GVNVHDVTVT TDKSFEQQVG VIADKDKDLS GAVPSDLNTS ELLTKAIDVD WVEFYGFKDA VTFATVDHSA FAYESAVVNG IRVLKTSDNN CWVNAVCIAL QYSKPHFISQ GLDAAWNKFV LGDVEIFVAF VYYVARLMKG DKGDAEDTLT KLSKYLANEA QVQLEHYSSC VECDAKFKNS VASINSAIVC ASVKRDGVQV GYCVHGIKYY SRVRSVRGRA IIVSVEQLEP CAQSRLLSGV AYTAFSGPVD KGHYTVYDTA KKSMYDGDRF VKHDLSLLSV TSVVMVGGYV APVNTVKPKP VINQLDEKAQ KFFDFGDFLI HNFVIFFTWL LSMFTLCKTA VTTGDVKIMA KAPQRTGVVL KRSLKYNLKA SAAVLKSKWW LLAKFTKLLL LIYTLYSVVL LCVRFGPFNF CSETVNGYAK SNFVKDDYCD GSLGCKMCLF GYQELSQFSH LDVVWKHITD PLFSNMQPFI VMVLLLIFGD NYLRCFLLYF VAQMISTVGV FLGYKETNWF LHFIPFDVIC DELLVTVIVI KVISFVRHVL FGCENPDCIA CSKSARLKRF PVNTIVNGVQ RSFYVNANGG SKFCKKHRFF CVDCDSYGYG STFITPEVSR ELGNITKTNV QPTGPAYVMI DKVEFENGFY RLYSCETFWR YNFDITESKY SCKEVFKNCN VLDDFIVFNN NGTNVTQVKN ASVYFSQLLC RPIKLVDSEL LSTLSVDFNG VLHKAYIDVL RNSFGKDLNA NMSLAECKRA LGLSISDHEF TSAISNAHRC DVLLSDLSFN NFVSSYAKPE EKLSAYDLAC CMRAGAKVVN ANVLTKDQTP IVWHAKDFNS LSAEGRKYIV KTSKAKGLTF LLTINENQAV TQIPATSIVA KQGAGDAGHS LTWLWLLCGL VCLIQFYLCF FMPYFMYDIV SSFEGYDFKY IENGQLKNFE APLKCVRNVF ENFEDWHYAK FGFTPLNKQS CPIVVGVSEI VNTVAGIPSN VYLVGKTLIF TLQAAFGNAG VCYDIFGVTT PEKCIFTSAC TRLEGLGGNN VYCYNTALME GSLPYSSIQA NAYYKYDNGN FIKLPEVIAQ GFGFRTVRTI ATKYCRVGEC VESNAGVCFG FDKWFVNDGR VANGYVCGTG LWNLVFNILS MFSSSFSVAA MSGQILLNCA LGAFAIFCCF LVTKFRRMFG DLSVGVCTVV VAVLLNNVSY IVTQNLVTMI AYAILYFFAT RSLRYAWIWC AAYLIAYISF APWWLCAWYF LAMLTGLLPS LLKLKVSTNL FEGDKFVGTF ESAAAGTFVI DMRSYEKLAN SISPEKLKSY AASYNRYKYY SGNANEADYR CACYAYLAKA MLDFSRDHND ILYTPPTVSY GSTLQAGLRK MAQPSGFVEK CVVRVCYGNT VLNGLWLGDI VYCPRHVIAS NTTSAIDYDH EYSIMRLHNF SIISGTAFLG VVGATMHGVT LKIKVSQTNM HTPRHSFRTL KSGEGFNILA CYDGCAQGVF GVNMRTNWTI RGSFINGACG SPGYNLKNGE VEFVYMHQIE LGSGSHVGSS FDGVMYGGFE DQPNLQVESA NQMLTVNVVA FLYAAILNGC TWWLKGEKLF VEHYNEWAQA NGFTAMNGED AFSILAAKTG VCVERLLHAI QVLNNGFGGK QILGYSSLND EFSINEVVKQ MFGVNLQSGK TTSMFKSISL FAGFFVMFWA ELFVYTTTIW VNPGFLTPFM ILLVALSLCL TFVVKHKVLF LQVFLLPSII VAAIQNCAWD YHVTKVLAEK FDYNVSVMQM DIQGFVNIFI CLFVALLHTW RFAKERCTHW CTYLFSLIAV LYTALYSYDY VSLLVMLLCA ISNEWYIGAI IFRICRFGVA FLPVEYVSYF DGVKTVLLFY MLLGFVSCMY YGLLYWINRF CKCTLGVYDF CVSPAEFKYM VANGLNAPNG PFDALFLSFK LMGIGGPRTI KVSTVQSKLT DLKCTNVVLM GILSNMNIAS NSKEWAYCVE MHNKINLCDD PETAQELLLA LLAFFLSKHS DFGLGDLVDS YFENDSILQS VASSFVGMPS FVAYETARQE YENAVANGSS PQIIKQLKKA MNVAKAEFDR ESSVQKKINR MAEQAAAAMY KEARAVNRKS KVVSAMHSLL FGMLRRLDMS SVDTILNMAR NGVVPLSVIP ATSAARLVVV VPDHDSFVKM MVDGFVHYAG VVWTLQEVKD NDGKNVHLKD VTKENQEILV WPLILTCERV VKLQNNEIMP GKMKVKATKG EGDGGITSEG NALYNNEGGR AFMYAYVTTK PGMKYVKWEH DSGVVTVELE PPCRFVIDTP TGPQIKYLYF VKNLNNLRRG AVLGYIGATV RLQAGKQTEF VSNSHLLTHC SFAVDPAAAY LDAVKQGAKP VGNCVKMLTN GSGSGQAITC TIDSNTTQDT YGGASVCIYC RAHVAHPTMD GFCQYKGKWV QVPIGTNDPI RFCLENTVCK VCGCWLNHGC TCDRTAIQSF DNSYLNRVRG SSAARLEPCN GTDIDYCVRA FDVYNKDASF IGKNLKSNCV RFKNVDKDDA FYIVKRCIKS VMDHEQSMYN LLKGCNAVAK HDFFTWHEGR TIYGNVSRQD LTKYTMMDLC FALRNFDEKD CEVFKEILVL TGCCSTDYFE MKNWFDPIEN EDIHRVYAAL GKVVANAMLK CVAFCDEMVL KGVVGVLTLD NQDLNGNFYD FGDFVLCPPG MGIPYCTSYY SYMMPVMGMT NCLASECFMK SDIFGQDFKT FDLLKYDFTE HKEVLFNKYF KYWGQDYHPD CVDCHDEMCI LHCSNFNTLF ATTIPNTAFG PLCRKVFIDG VPVVATAGYH FKQLGLVWNK DVNTHSTRLT ITELLQFVTD PTLIVASSPA LVDKRTVCFS VAALSTGLTS QTVKPGHFNK EFYDFLRSQG FFDEGSELTL KHFFFTQKGD AAIKDFDYYR YNRPTMLDIG QARVAYQVAA RYFDCYEGGC ITSREVVVTN LNKSAGWPLN KFGKAGLYYE SISYEEQDAI FSLTKRNILP TMTQLNLKYA ISGKERARTV GGVSLLATMT TRQFHQKCLK SIVATRNATV VIGTTKFYGG WDNMLKNLMA DVDDPKLMGW DYPKCDRAMP SMIRMLSAMI LGSKHVTCCT ASDKFYRLSN ELAQVLTEVV YSNGGFYFKP GGTTSGDATT AYANSVFNIF QAVSSNINCV LSVNSSNCNN FNVKKLQRQL YDNCYRNSNV DESFVDDFYG YLQKHFSMMI LSDDSVVCYN KTYAGLGYIA DISAFKATLY YQNGVFMSTA KCWTEEDLSI GPHEFCSQHT MQIVDENGKY YLPYPDPSRI ISAGVFVDDI TKTDAVILLE RYVSLAIDAY PLSKHPKPEY RKVFYALLDW VKHLNKTLNE GVLESFSVTL LDEHESKFWD ESFYASMYEK STVLQAAGLC VVCGSQTVLR CGDCLRRPML CTKCAYDHVF GTDHKFILAI TPYVCNTSGC NVNDVTKLYL GGLNYYCVDH KPHLSFPLCS AGNVFGLYKS SALGSMDIDV FNKLSTSDWS DIRDYKLAND AKESLRLFAA ETVKAKEESV KSSYAYATLK EIVGPKELLL LWESGKAKPP LNRNSVFTCF QITKDSKFQV GEFVFEKVDY GSDTVTYKST ATTKLVPGML FILTSHNVAP LRAPTMANQE KYSTIYKLHP SFNVSDAYAN LVPYYQLIGK QRITTIQGPP GSGKSHCSIG IGVYYPGARI VFTACSHAAV DSLCAKAVTA YSVDKCTRII PARARVECYS GFKPNNNSAQ YVFSTVNALP EVNADIVVVD EVSMCTNYDL SVINQRISYK HIVYVGDPQQ LPAPRVLISK GVMEPIDYNV VTQRMCAIGP DVFLHKCYRC PAEIVNTVSE LVYENKFVPV KEASKQCFKI FERGSVQVDN GSSINRRQLD VVKRFIHKNS TWSKAVFISP YNSQNYVAAR LLGLQTQTVD SAQGSEYDYV IFAQTSDTAH ACNANRFNVA ITRAKKGIFC IMSDRTLFDA LKFFEITMTD LQSESSCGLF KDCARNPIDL PPSHATTYLS LSDRFKTSGD LAVQIGNNNV CTYEHVISYM GFRFDVSMPG SHSLFCTRDF AMRHVRGWLG MDVEGAHVTG DNVGTNVPLQ VGFSNGVDFV AQPEGCVLTN TGSVVKPVRA RAPPGEQFTH IVPLLRKGQP WSVLRKRIVQ MIADFLAGSS DVLVFVLWAG GLELTTMRYF VKIGAVKHCQ CGTVATCYNS VSNDYCCFKH ALGCDYVYNP YVIDIQQWGY VGSLSTNHHA ICNVHRNEHV ASGDAIMTRC LAVYDCFVKN VDWSITYPMI ANENAINKGG RTVQSHIMRA AIKLYNPKAI HDIGNPKGIR CAVTDAKWYC YDKNPINSNV KTLEYDYMTH GQMDGLCLFW NCNVDMYPEF SIVCRFDTRT RSTLNLEGVN GGSLYVNNHA FHTPAYDKRA MAKLKPAPFF YYDDGSCEVV HDQVNYVPLR ATNCITKCNI GGAVCSKHAN LYRAYVESYN IFTQAGFNIW VPTTFDCYNL WQTFTEVNLQ GLENIAFNVV NKGSFVGADG ELPVAISGDK VFVRDGNTDN LVFVNKTSLP TNIAFELFAK RKVGLTPPLS ILKNLGVVAT YKFVLWDYEA ERPLTSFTKS VCGYTDFAED VCTCYDNSIQ GSYERFTLST NAVLFSATAV KTGGKSLPAI KLNFGMLNGN AIATVKSEDG NIKNINWFVY VRKDGKPVDH YDGFYTQGRN LQDFLPRSTM EEDFLNMDIG VFIQKYGLED FNFEHVVYGD VSKTTLGGLH LLISQVRLSK MGILKAEEFV AASDITLKCC TVTYLNDPSS KTVCTYMDLL LDDFVSVLKS LDLTVVSKVH EVIIDNKPWR WMLWCKDNAV ATFYPQLQSA EWKCGYSMPG IYKTQRMCLE PCNLYNYGAG LKLPSGIMFN VVKYTQLCQY FNSTTLCVPH NMRVLHLGAG SDYGVAPGTA VLKRWLPHDA IVVDNDVVDY VSDADFSVTG DCATVYLEDK FDLLISDMYD GRTKAIDGEN VSKEGFFTYI NGFICEKLAI GGSIAIKVTE YSWNKKLYEL VQRFSFWTMF CTSVNTSSSE AFVVGINYLG DFAQGPFIDG NIIHANYVFW RNSTVMSLSY NSVLDLSKFN CKHKATVVVQ LKDSDINEMV LSLVRSGKLL VRGNGKCLSF SNHLVSTK //